Optometrists in Ishpeming, MI Accepting Medicare
6 Optometrists found. Showing 1 - 6
 Ryan Matthew Meyer, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1366 Us Highway 41 W, Ishpeming, MI 49849 Phone: 906-485-1300 |
 Sara Beth Meyer, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1366 Us Highway 41 W, Ishpeming, MI 49849 Phone: 906-485-1300 |
Ronald Jack Meyer, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1366 Us Highway 41 W, Ishpeming, MI 49849 Phone: 906-485-1300 |
Gunnar Marc Meyer, OD Optometrist Medicare: Medicare Enrolled Practice Location: 1366 Us Highway 41 W, Ishpeming, MI 49849 Phone: 906-485-1300 |
 Meyer Family Vision, P.c. Optometrist Medicare: Medicare Enrolled Practice Location: 1366 Us Highway 41 W, Ishpeming, MI 49849 Phone: 906-485-1300 Fax: 906-485-4040 |
U P Eye Specialists Plc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 901 Lakeshore Dr, Suite 102, Ishpeming, MI 49849 Phone: 906-225-4512 Fax: 906-225-4514 |
News Archive
Impaired blood vessel and kidney function underlie heart disease risk in people with HIV
A new study has found impaired blood vessel function in those living with human immunodeficiency virus (HIV).
KHN column – Insuring your health: Should patients get contraceptives from health plans at no cost?
"The average American woman who wants two children spends roughly five years trying to get pregnant or being pregnant. She spends a much longer time - 30 years, on average - trying to avoid pregnancy, often at no small expense. That may soon change, at least the expense part" (7/6).
RWJF announces recipients of four new grants from Future of Nursing National Research Agenda
The Robert Wood Johnson Foundation today announced the recipients of four new grants from its Future of Nursing National Research Agenda. The new grants examine nurse residency programs and scope of practice regulations.
bioTheranostics presents positive outcomes from CancerTYPE ID, Breast Cancer Index clinical studies
bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from clinical studies utilizing the company's CancerTYPE ID® and Breast Cancer Index® molecular oncology tests. Data from the studies were presented this week at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting in Chicago.
› Verified 7 days ago
Physical Therapists
Chiropractors
Occupational Therapists
Optometrists
Speech-Language Pathologists